Ciba-Geigy

Overview

Ciba-Geigy was a Swiss pharmaceutical company that merged to form Novartis in 1996. It was originally known for its chemical and pharmaceutical products. Now part of Novartis, the organization continues research and development in pharmaceuticals.

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Ciba-Geigy is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Ciba-Geigy holds 0 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CHLORTHALIDONE USPInactive1987-03-26
• CGP 17,582BInactive1984-05-21
• CGP LL637 ADJUVANT--CHEMISTRY & GMPInactive1984-02-09
• ADJUVANT CGP 11637:TOXICITY STUDIES & RESULTS CONDUCTED IN EUROPEAN FAInactive1984-02-09
• 2(2'-HYDROXY-5-METHYLPHENYL) BENZOTRIAZOLEInactive1971-09-20

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Ciba-Geigy in our records. PharmaTek screens the full directory against live FDA enforcement data.